ELYPSE-7: a randomized placebo-controlled phase IIa trial with CYT107 exploring the restoration of CD4+ lymphocyte count in lymphopenic metastatic breast cancer patients
Titel:
ELYPSE-7: a randomized placebo-controlled phase IIa trial with CYT107 exploring the restoration of CD4+ lymphocyte count in lymphopenic metastatic breast cancer patients
Auteur:
Trédan, O. Ménétrier-Caux, C. Ray-Coquard, I. Garin, G. Cropet, C. Verronèse, E. Bachelot, T. Rebattu, P. Heudel, P.E. Cassier, P. Chabaud, S. Croughs, T. Dupont, P. Cadore, A.C. Clapisson, G. Delgado, A. Bardin-dit-Courageot, C. Rigal, C. N’Kodia, A. Gilles-Afchain, L. Morre, M. Pérol, D. Blay, J.Y. Caux, C.